🇺🇸 FDA
Patent

US 9345790

Cobalt-based MRI contrast agent and imaging system

granted A61KA61K49/06A61K49/10

Quick answer

US patent 9345790 (Cobalt-based MRI contrast agent and imaging system) held by The Board of Regents of the University of Texas System expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K49/06, A61K49/10, A61K49/103, A61K49/1824